FdaApplication
ANDA 202202
Identifiers
- fda_app_no: ANDA202202
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS |
| application_type | ANDA |
| approval_date | 2013-03-04 |
Products (9)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| WARFARIN SODIUM | WARFARIN SODIUM | 1MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 6MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 2MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 3MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 7.5MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 10MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 5MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 2.5MG | TABLET;ORAL |
| WARFARIN SODIUM | WARFARIN SODIUM | 4MG | TABLET;ORAL |
9 products